Skip to content
PubMed This is a summary of 26 peer-reviewed journal articles Updated
Radiology · Breast Cysts

Treatment and Management of Breast Cysts

At a Glance

Most breast cysts are benign and do not need treatment unless they cause pain. Ultrasound appearance guides care: simple cysts are usually observed, complicated cysts need follow-up imaging, and complex cystic and solid masses generally require biopsy.

Deciding how to manage a breast cyst depends almost entirely on how it looks on an ultrasound and whether it is causing you pain. Because the vast majority of cysts are benign (non-cancerous), the goal of treatment is usually to provide peace of mind or physical relief, rather than to remove a dangerous growth [1][2].

Management Based on Your Cyst Type

Your care team will use your BI-RADS category and the cyst’s physical characteristics to determine the next steps. Management is an individualized decision.

  • Simple Cysts (BI-RADS 2): These are entirely benign. The standard care is observation—meaning no further imaging or treatment is needed unless the cyst becomes painful [1][2].
  • Complicated Cysts (BI-RADS 3): These are often considered “probably benign” (less than a 2% risk of cancer) [3]. Doctors usually recommend short-interval surveillance, which typically involves a follow-up ultrasound in 6 months, followed by checks at 12 and 24 months to ensure the cyst remains stable [4][5]. (Depending on appearance, some complicated cysts may be categorized as BI-RADS 2).
  • Complex Cystic and Solid Masses (BI-RADS 4): These contain solid components or thick walls and require tissue sampling (biopsy) [1][6]. While many complex cysts are still benign—such as a papilloma (a wart-like growth)—a biopsy is necessary to rule out malignancy [7][8].

Common Procedures for Cysts

If your doctor recommends an intervention, it will likely be one of the following procedures. Most are performed in an outpatient setting with minimal recovery time.

Fine-Needle Aspiration (FNA)

This procedure is used to drain fluid from a cyst. It is often performed if a simple cyst is “tense” and causing pain, or to see if a lump disappears once the fluid is removed [2][9]. It is generally not the preferred way to diagnose a suspicious solid component.

  • What to expect: After numbing the area, the doctor uses a very thin needle (often under ultrasound guidance) to withdraw the fluid [10][11]. If the lump disappears and the fluid is not bloody, no further treatment is usually needed [2].
  • The “Triple Test” and Concordance: Doctors look for concordance, meaning the clinical feel, the imaging, and the fluid results all tell the same story [12]. If a lump doesn’t fully disappear after drainage, if the aspirate is bloody, or if there is discordance, further testing is required [9].

Core Needle Biopsy (CNB)

If a cyst has solid parts (BI-RADS 4), a fine needle isn’t enough; the doctor needs a small piece of the solid tissue [13][14].

  • What to expect: A slightly larger, hollow needle is used to take several small “cores” of tissue [15]. You will receive local anesthesia. Afterward, a tiny metal tissue marker (clip) is often placed at the site so it can be easily located on future mammograms [16][17].
  • Recovery: You may have some bruising, mild soreness, or a small risk of bleeding or infection for a few days, but most people return to normal activities quickly [18][19]. Contact your care team if you have a fever, excessive swelling, or redness.

Surgical Excision

Surgery is rarely the first step but may be considered after shared decision-making in specific situations:

  • Recurrence: If a cyst is drained but repeatedly grows back and causes significant pain [20][21].
  • Suspicious Findings: If a biopsy shows “atypical” cells or if the imaging and biopsy results don’t match (discordance) [22][23].
  • Bloody Fluid: Rapidly growing cysts that fill with bloody fluid may be surgically evaluated to ensure a complete diagnosis [20].

Decision Summary Table

Cyst Subtype Primary Management When to Intervene
Simple Observation [2] If it causes pain or pressure (FNA) [9].
Complicated Ultrasound at 6, 12, 24 mo [4] If it changes shape or develops solid parts [24].
Complex Image-guided Biopsy [13] Required to rule out underlying malignancy [1].

Remember that an “insufficient” or “atypical” result from a needle test is not a final answer. In those cases, your doctor will likely recommend a repeat biopsy, vacuum-assisted excision, surveillance, or surgical removal to be certain of the diagnosis [25][26].

Common questions in this guide

Do breast cysts always need treatment?
No. Most simple breast cysts are benign and can be observed without treatment or additional imaging unless they cause pain or pressure. Fine-needle aspiration may be used when a cyst is uncomfortable or tense.
How do doctors decide whether to monitor or biopsy a breast cyst?
Ultrasound appearance and the BI-RADS category guide the decision. Simple cysts are usually observed, complicated cysts often receive follow-up ultrasound, and complex cystic and solid masses generally need a core needle biopsy to evaluate the solid tissue.
What is breast cyst aspiration, and when is it used?
Fine-needle aspiration drains fluid from a cyst and may relieve a painful, tense simple cyst. If the lump disappears and the fluid is not bloody, further treatment is often unnecessary. A persistent lump, bloody fluid, or a mismatch between the examination, imaging, and fluid findings requires additional evaluation.
How often do complicated breast cysts need follow-up imaging?
A complicated cyst classified as BI-RADS 3 is commonly checked with ultrasound at about 6, 12, and 24 months to confirm that it remains stable. The schedule can vary based on the cyst's appearance and your clinician's recommendation.
What should I expect after a core needle biopsy of a breast cyst?
The area is numbed before a slightly larger needle removes several small tissue samples, and a tiny marker clip may be placed. Mild soreness or bruising is common, and most people return to normal activities quickly. Contact your care team for fever, excessive swelling, or increasing redness.
What happens if a breast cyst biopsy is insufficient or does not match the imaging?
An insufficient, atypical, or discordant result is not necessarily the final answer. Depending on the findings, your doctor may recommend a repeat biopsy, vacuum-assisted excision, additional surveillance, or surgical removal to clarify the diagnosis.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Does my imaging show a solid component or just debris, and how does that influence the decision to biopsy rather than aspirate?
  2. 2.Can this procedure be done under ultrasound guidance to ensure the correct part of the lesion is sampled?
  3. 3.How do the pathology results from my biopsy compare to what you saw on my imaging? Are they concordant?
  4. 4.What should I watch out for in terms of bleeding or infection after the procedure?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (26)
  1. 1

    Cystic Breast Lesions: Diagnostic Approach and US Assessment.

    Lim HS, Lee HJ, Lee JS, et al.

    Radiographics : a review publication of the Radiological Society of North America, Inc 2025; (45(5)):e240179 doi:10.1148/rg.240179.

    PMID: 40244873
  2. 2

    [Management of a breast cystic syndrome: Guidelines].

    Uzan C, Seror JY, Seror J

    Journal de gynecologie, obstetrique et biologie de la reproduction 2015; (44(10)):970-9.

    PMID: 26527028
  3. 3

    Understanding BI-RADS Category 3.

    Fazeli S, Stepenosky J, Guirguis MS, et al.

    Radiographics : a review publication of the Radiological Society of North America, Inc 2025; (45(1)):e240169 doi:10.1148/rg.240169.

    PMID: 39636752
  4. 4

    Cancer Yield and Patterns of Follow-up for BI-RADS Category 3 after Screening Mammography Recall in the National Mammography Database.

    Berg WA, Berg JM, Sickles EA, et al.

    Radiology 2020; (296(1)):32-41 doi:10.1148/radiol.2020192641.

    PMID: 32427557
  5. 5

    Follow-Up Intervals for Breast Imaging Reporting and Data System Category 3 Lesions on Screening Ultrasound in Screening and Tertiary Referral Centers.

    Huh S, Suh HJ, Kim EK, et al.

    Korean journal of radiology 2020; (21(9)):1027-1035 doi:10.3348/kjr.2019.0747.

    PMID: 32691538
  6. 6

    Accuracy and Upgrading of CNB and BI-RADS Diagnoses Compared to Excision: A Clinicopathological-Radiological Correlation of Papillary Breast Lesions and Neoplasms.

    Fawzy MM, Sheta H, Abd El Hafez A, et al.

    Asian Pacific journal of cancer prevention : APJCP 2022; (23(11)):3959-3969 doi:10.31557/APJCP.2022.23.11.3959.

    PMID: 36444611
  7. 7

    Papillary Neoplasms of the Breast: WHO Classification, Multimodality Imaging, and Radiologic-Pathologic Correlation.

    Thai JN, Vickery J, Boyraz B, et al.

    Radiographics : a review publication of the Radiological Society of North America, Inc 2025; (45(8)):e240091 doi:10.1148/rg.240091.

    PMID: 40674246
  8. 8

    Complex Solid and Cystic Breast Cancer: A Series of Six Case Reports.

    Mehta N, Rousslang L, Shokouh-Amiri M, et al.

    Journal of radiology case reports 2020; (14(2)):21-44 doi:10.3941/jrcr.v14i2.3712.

    PMID: 32184934
  9. 9

    A rare case of persistent large cystic breast tumor mimicking as malignant cystic breast cancer.

    Teh MS, Teoh LY, See MH

    Journal of cancer research and therapeutics 2022; (18(6)):1804-1807 doi:10.4103/jcrt.JCRT_631_20.

    PMID: 36412448
  10. 10

    Clinical practice guidelines from the French College of Gynecologists and Obstetricians (CNGOF): benign breast tumors - short text.

    Lavoué V, Fritel X, Antoine M, et al.

    European journal of obstetrics, gynecology, and reproductive biology 2016; (200()):16-23.

    PMID: 26967341
  11. 11

    Role of triple test score in the evaluation of palpable breast lump.

    Kachewar SS, Dongre SD

    Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology 2015; (36(2)):123-7 doi:10.4103/0971-5851.158846.

    PMID: 26157290
  12. 12

    Correlation of Histopathology and Radiological Findings Among the Diverse Breast Lesions in a Tertiary Care Centre.

    Mohan R, Selvakumar A S, S R, et al.

    Cureus 2024; (16(1)):e52097 doi:10.7759/cureus.52097.

    PMID: 38344545
  13. 13

    Fine-needle versus core-needle biopsy - which one to choose in preoperative assessment of focal lesions in the breasts? Literature review.

    Łukasiewicz E, Ziemiecka A, Jakubowski W, et al.

    Journal of ultrasonography 2017; (17(71)):267-274 doi:10.15557/JoU.2017.0039.

    PMID: 29375902
  14. 14

    A Comparison of the Prognostic Effects of Fine Needle Aspiration and Core Needle Biopsy in Patients with Breast Cancer: A Nationwide Multicenter Prospective Registry.

    Gwak H, Woo SS, Oh SJ, et al.

    Cancers 2023; (15(18)) doi:10.3390/cancers15184638.

    PMID: 37760607
  15. 15

    Troubleshooting to Overcome Technical Challenges in Image-guided Breast Biopsy.

    Chesebro AL, Chikarmane SA, Ritner JA, et al.

    Radiographics : a review publication of the Radiological Society of North America, Inc 2017; (37(3)):705-718 doi:10.1148/rg.2017160117.

    PMID: 28410063
  16. 16

    Advantages and Challenges of Using Breast Biopsy Markers.

    Alshafeiy TI, Matich A, Rochman CM, Harvey JA

    Journal of breast imaging 2022; (4(1)):78-95 doi:10.1093/jbi/wbab052.

    PMID: 38422410
  17. 17

    Breast tissue markers: Why? What's out there? How do I choose?

    Shah AD, Mehta AK, Talati N, et al.

    Clinical imaging 2018; (52()):123-136 doi:10.1016/j.clinimag.2018.07.003.

    PMID: 30059952
  18. 18

    Hemorrhagic Complications Following Ultrasound-Guided Breast Biopsy: A Prospective Patient-Centered Study.

    Yoen H, Chung HA, Lee SM, et al.

    Korean journal of radiology 2024; (25(2)):157-165 doi:10.3348/kjr.2023.0874.

    PMID: 38288896
  19. 19

    Nontechnical Factors and Postprocedural Considerations for Image-guided Breast Biopsy.

    Dodelzon K, Bhole S, Coffey K, et al.

    Journal of breast imaging 2025; (7(1)):85-93 doi:10.1093/jbi/wbae066.

    PMID: 39499496
  20. 20

    Breast Trauma and Triple-Negative Hemorrhagic Cystic Carcinoma: Management and Treatment.

    Cotesta M, Buonomo OC, De Majo A, et al.

    The American journal of case reports 2020; (21()):e925014 doi:10.12659/AJCR.925014.

    PMID: 33311426
  21. 21

    Adult cystic lymphangioma in the inner quadrant of the breast-Rare location for a rare disease: A case report.

    Rusdianto E, Murray M, Davis J, Caveny A

    International journal of surgery case reports 2016; (20()):123-6.

    PMID: 26852362
  22. 22

    Impact of multidisciplinary radiologic-pathologic correlation conference for benign image-guided breast biopsies on discordance rates and patient outcomes in a community teaching hospital.

    Olayinka O, Kaur G, Agarwal R, et al.

    Annals of diagnostic pathology 2022; (57()):151864 doi:10.1016/j.anndiagpath.2021.151864.

    PMID: 34972038
  23. 23

    Improving Patient Care by Incorporation of Multidisciplinary Breast Radiology-Pathology Correlation Conference.

    Prakash S, Venkataraman S, Slanetz PJ, et al.

    Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes 2016; (67(2)):122-9.

    PMID: 26632099
  24. 24

    Growing BI-RADS category 3 lesions on follow-up breast ultrasound: malignancy rates and worrisome features.

    Ha SM, Chae EY, Cha JH, et al.

    The British journal of radiology 2018; (91(1087)):20170787 doi:10.1259/bjr.20170787.

    PMID: 29658793
  25. 25

    Risk Stratification of Breast Fine-Needle Aspiration Biopsy Specimens Performed without Radiologic Guidance by Application of the International Academy of Cytology Yokohama System for Reporting Breast Fine-Needle Aspiration Cytopathology.

    Sarangi S, Rao M, Elhence PA, et al.

    Acta cytologica 2021; (65(6)):483-493 doi:10.1159/000518790.

    PMID: 34535580
  26. 26

    The International Academy of Cytology Yokohama System for Reporting Breast Fine-Needle Aspiration Biopsy Cytopathology.

    Field AS, Raymond WA, Rickard M, et al.

    Acta cytologica 2019; (63(4)):257-273 doi:10.1159/000499509.

    PMID: 31112942

This page explains breast cyst management and procedures for informational purposes only and does not constitute medical advice. Your breast imaging team and clinician should guide decisions about your specific cyst and follow-up.

Get notified when new evidence is published on breast cyst.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.